Skip to main content
Michael Hoffer, MD, Otolaryngology (ENT), Miami, FL

Michael Ellis Hoffer MD

Neurotology


Physician

Join to View Full Profile
  • 1120 NW 14th StFl 5Miami, FL 33136

  • Phone+1 305-243-3564

  • Fax+1 305-243-2009

Dr. Hoffer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Otolaryngology - Head and Neck Surgery, 1988 - 1993
  • University of California San Diego School of Medicine
    University of California San Diego School of MedicineClass of 1988

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1989 - 2026
  • FL State Medical License
    FL State Medical License 1993 - 2026
  • PA State Medical License
    PA State Medical License 1990 - 2002
  • Otolaryngology
    American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
  • Neurotology
    American Board of Otolaryngology - Head and Neck Surgery Neurotology

Awards, Honors, & Recognition

  • Fellow (FACS) American College of Surgeons
  • Fellow (FAAO-HNS) American Academy of Otolaryngology - Head and Neck Surgery

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Miller School’s Dr. Michael Hoffer Leads 2025 Triological Society Combined Sections Meeting
    Miller School’s Dr. Michael Hoffer Leads 2025 Triological Society Combined Sections MeetingJanuary 31st, 2025
  • Convinced ‘Havana Syndrome’ Is Real, Biden Team Issues Sharper Guidance for U.S. Personnel
    Convinced ‘Havana Syndrome’ Is Real, Biden Team Issues Sharper Guidance for U.S. PersonnelOctober 5th, 2021
  • Lobe Sciences Announces Data Demonstrating That Its Combination Therapeutic Candidates Are Significantly More Effective Than Monotherapy in mTBI and PTSD
    Lobe Sciences Announces Data Demonstrating That Its Combination Therapeutic Candidates Are Significantly More Effective Than Monotherapy in mTBI and PTSDSeptember 28th, 2021
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: